Monocyte chemoattractant protein-1 involvement in the α-tocopherol-induced reduction of atherosclerotic lesions in apolipoprotein E knockout mice

British Journal of Nutrition

Volumn 90, Issue 1, 2003, Pages 3-11

  Peluzio, Maria C G ^b   Miguel Jr , Emir ^a   Drumond, Thaís C ^a   César, Giovana C ^a   Santiago, Helton C ^a   Teixeira, Mauro M ^a   Vieira, Enio C ^a   Arantes, Rosa M E ^a   Alvarez Leite, Jacqueline I ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

Author keywords

Tocopherol; Antioxidant; Apolipoprotein E knockout mice; Atherosclerosis; Monocyte chemoattractant protein 1

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN E; CHOLESTEROL; LIPOPROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN; TOCOPHEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG TISSUE LEVEL; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LIPOPROTEIN BLOOD LEVEL; LIVER; MOUSE; MOUSE MUTANT; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SERUM; TISSUE LEVEL; ANIMAL; AORTA DISEASE; ARTERIOSCLEROSIS; BLOOD; C57BL MOUSE; CHEMISTRY; GENETICS; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALIA;

ALPHA-TOCOPHEROL; ANIMALS; AORTIC DISEASES; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CHEMOKINE CCL2; CHOLESTEROL; IMMUNOHISTOCHEMISTRY; LIPOPROTEINS; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0041869393     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1079/BJN2003870     Document Type: Article

References (65)

1. Aiello RJ, Bourassa P-AK, Lindsey S, et al. (1999) Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 19, 1518-1525.
2. Allain CC, Poon LS, Chan CSG, Richmond W & Fu PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20, 470-475.
3. Asmis R & Jelk J (2000) Vitamin E supplementation of human macrophages prevents neither foam cell formation nor increased susceptibility of foam cells to lysis by oxidized LDL. Arterioscler Thromb Vasc Biol 20, 2078-2086.
4. Azen SP, Qian D, Mack WJ, et al. (1996) Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering. Circulation 94, 2369-2372.
5. Boaz M, Smetana S, Weinstein T, et al. (2000) Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial. Lancet 356, 1213-1218.
6. Boisvert WA, Black AS & Curtiss LK (1999) Apo A1 reduces free cholesterol accumulation in atherosclerosis lesions of apo E-deficient mice transplanted with apo E-expressing macrophages. Arterioscler Thromb Vasc Biol 19, 525-530.
7. Boring L, Gosling J, Cleary M & Charo IF (1998) Decreases lesion formation in CCR2-mice reveals a role for chemokines in the formatin of atherosclerosis. Nature 394, 894-897.
8. Brown BG, Cheung MC, Lee AC, Zhao XQ & Chait A (2002) Antioxidant vitamins and lipid therapy: End of a long romance? Arterioscler Thromb Vasc Biol 22, 1535-1546.
9. Brown BG, Zhao XQ, Chait A, et al. (2001) Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. New Eng J Med 345, 1583-1592.
10. Chisolm GM & Steinberg D (2000) The oxidative modification hypothesis of atherogenesis: An overview. Free Radic Biol Med 28, 1815-1826.
11. Collaborative Group of the Primary Prevention Project (2001) Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomized trial in general practice. Lancet 357, 89-95.
12. Crawford RS, Kirk EA, Rosenfeld ME, LeBoeuf RC & Chait A (1998) Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol 18, 1506-1513.
13. Devaraj S, Harris A & Jialal I (2002) Modulation of monocyte-macrophage function with α-tocopherol: Implications for atherosclerosis. Nutr Rev 60, 8-13.
14. Djahansouzi S, Braesen JH, Koenig K, Beisiegel V & Kontush A (2001) The effect of pharmacological doses of different antioxidants on oxidation parameters and atherogenesis in hyperlipidaemic rabbits. Atherosclerosis 154, 387-398.
15. Fazio S, Babaev VR, Murray AB, et al. (1997) Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proc Natl Acad Sci USA 94, 4647-4652.
16. Folch J, Lees M & Stanley S (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497-509.
17. Frei B (1999) On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction. Proc Soc Exp Biol Med 222, 196-204.
18. GISSI-Prevenzione Investigators (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Lancet 354, 447-455.
19. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R & Mathieu C (2001) An overview of real-time quantitative PCR: Applications to quantify cytokine gene expression. Methods 25, 386-401.
20. Gu L, Okada Y, Clinton SK, et al. (1998) Absence of monocyte chemoattractant protein 1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 2, 275-281.
21. Hayek T, Oiknine J, Brook JG & Aviram M (1994) Increased plasma and lipoprotein lipid peroxidation in Apo-E deficient mice. Biochem Biophys Res Comm 3, 1567-1574.
22. Heinecke JW (2001) Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis. Arterioscler Thromb Vasc Biol 21, 1261-1264.
23. Hodis HN, Mack WJ, LaBree L, et al. (1995) Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 273, 1849-1854.
24. Howard HN, Wendy MJ, LaBree L, et al. (2002) Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: The Vitamin A Atherosclerosis Prevention Study (VEAPS). Circulation 106, 1453-1459.
25. Huang HY, Appel LJ, Croft KD, Miller ER 3rd, Mori TA & Puddey IB (2002) Effects of vitamin C and vitamin E on in vivo lipid peroxidation: Results of a randomized controlled trial. Am J Clin Nutr 76, 549-555.
26. Iuliano L, Micheletta F, Maranghi M, Frati G, Diczfalusy U & Violi F (2001) Bioavailability of vitamin E as function of food intake in healthy subjects: Effects on plasma peroxide-scavenging activity and cholesterol-oxidation products. Arterioscler Thromb Vasc Biol 21, e34-e37.
27. Kayden HJ & Traber MG (1993) Absorption, lipoprotein transport and regulation of plasma concentrations of vitamin E in humans. J Lipid Res 34, 343-358.
28. Landmesser U & Harrison DG (2001) Oxidant stress as a marker for cardiovascular events: Ox marks or spot. Circulation 104, 2638-2640.
29. Libby P, Geng YJ, Masanori A, et al. (1996) Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol 7, 330-335.
30. Lonn E, Yusuf S, Dzavik V, et al. (2001) Effects of ramipril and vitamin E on atherosclerosis: The study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 103, 919-925.
31. McCall MR & Frei B (1999) Can antioxidant vitamins materially reduce oxidative damage in humans? Free Radic Biol Med 26, 1034-1053.
32. Munday JS, Thompson KG, James KAC & Manktelow BW (1998) Dietary antioxidants do not reduce fatty streak formation in the C57BL/6 mouse atherosclerosis model. Arterioscler Thromb Vasc Biol 18, 114-119.
33. Nakashima Y, Plump AS, Raines EW, Breslow JL & Ross R (1994) Apo E-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb Vasc Biol 14, 133-140.
34. Nelken NA, Coughlin SR, Gordon D & Wilcox JN (1991) Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 88, 1121-1127.
35. Overbergh L, Valckx D, Waer M & Mathieu C (1998) Quantification of murine cytokine mRNAs using real-time quantitative reverse transcriptase PCR. Cytokine 11, 305-312.
36. Packer L (1991) Protective role of vitamin E in biological systems. Am J Clin Nutr 53, 1050S-1055S.
37. Paigen B, Morrow A, Holmes PA, Mitchell D & Williams A (1987) Quantitative assessment of atherosclerosis lesions in mice. Atherosclerosis 68, 231-240.
38. Parthasarathy S, Santanam N & Augé N (1998) Oxidized low-density lipoprotein, a two-faced Janus in coronary artery disease? Biochem Pharmacol 56, 279-284.
39. Peluzio MCG, Homen APP, Cesar GC, et al. (2001) Influences of α-tocopherol on cholesterol metabolism and fatty streak development in apo E deficient atherogenic diet. Braz J Med Biol Res 35, 161-173.
40. Phonpanichrasamee C, Komaratat P & Wilairat P (1990) Hypocholesterolemic effect of vitamin E on cholesterol-fed rabbit. Int J Vitam Nutr Res 60, 240-244.
41. Praticò D, Tangirala RK, Rader DJ, Rokach J & FitzGerald GA (1998) Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in Apo-E deficient mice. Nat Med 10, 1189-1192.
42. Reddick RL, Zhang SH & Maeda N (1994) Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler Thromb Vasc Biol 14, 141-147.
43. Reeves PG, Nielsen FH & Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123, 1936-1951.
44. Ricciarelli R, Zing JM & Azzi A (2002) The 80th anniversary of vitamin E: Beyond its antioxidant properties. Biol Chem 383, 57-65.
45. Rilley JS & Stouffer GA (2000) The antioxidant vitamins and coronary heart disease: Part I. Basic science background and clinical observational studies. Am J Med Sci 324, 314-320.
46. Rimm EB, Stampfer MJ, Ascherio A, Giovanannucci E, Colditz GA, & Willett WC (1993) Vitamin E consumption and the risk of coronary heart disease in men. New Engl J Med 328, 1450-1456.
47. Salonen JT, Nyyssonen K, Salonen R, et al. (2000) Antioxidant supplementation in atherosclerosis prevention (ASAP) study: A randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Int Med 248, 377-386.
48. Sies H, Stahl W & Sundquist AR (1992) Antioxidant functions of vitamins. Vitamins E and C, beta-carotene and other carotenoids. Ann NY Acad Sci 669, 7-20.
49. Steinberg D (2000) Is there a potential therapeutic role for vitamin E or other antioxidants in atherosclerosis? Curr Opin Lipidol 11, 603-607.
50. Steinberg D (1992) Antioxidants in prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung and Blood Institute Workshop, September 5-6, 1991, Bethesda, Maryland. Circulation 85, 2337-2344.
51. Steinberg D & Witztum JL (2002) Is the oxidative modification hypothesis relevant to human atherosclerosis?, Do the antioxidant trials conducted to date refute the hypothesis? Circulation 105, 2107-2111.
52. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K & Mitchinson MJ (1996) Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347, 781-786.
53. Stocker R (1999) Dietary and pharmacological antioxidants in atherosclerosis. Curr Opin Lipidol 10, 589-597.
54. Takeya M, Yoshimura T, Leonharf EJ & Takahashi K (1993) Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 antibody. Hum Pathol 24, 534-539.
55. Tangirala RK, Rubin EM & Palinski W (1995) Quantification of atherosclerosis in murine models: Correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-dificient and apolipoprotein-E deficient mice. J Lipid Res 36, 2320-2328.
56. Terasawa Y, Ladha Z, Leonard SW, et al. (2000) Increased atherosclerosis in hyperlipidemic mice deficient in α-tocopherol transfer protein and vitamin E. Proc Natl Acad Sci USA 97, 13830-13834.
57. The Heart Outcomes Prevention Evaluation Study Investigators (2000) Vitamin E supplementation and cardiovascular events in high-risk patients. New Engl J Med 342, 154-160.
58. Tsimikas S, Shortal BP, Witztum JL & Palinski W (2000) In vivo uptake of radiolabeled MDA, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions to their regression. Arterioscler Thromb Vasc Biol 20, 689-697.
59. Ueda T & Igarashi O (1990) Determination of vitamin E in biological specimens and foods b HPLC-pretreatment of samples and extraction of tocopherols. J Micronutr Anal 7, 79-96.
60. Upston JM, Terentis AC, Morris K, Keaney JF Jr & Stocker R (2002) Oxidized lipid accumulates in the presence of alpha-tocopherol in atherosclerosis. Biochem J 363, 753-760.
61. Virmani R, Kolodgie FD, Burke AP, Farb A & Schwartz SM (2000) Lessons from sudden coronary death. A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20, 1262-1275.
62. Wefers H & Sies H (1988) The protection by ascorbate and glutathione against microsomal lipid peroxidation is dependent on vitamin E. FEBS Lett 174, 353-357.
63. Williams RJ, Motteram JM, Sharp CH & Gallagher PJ (1992) Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits. Atherosclerosis 94, 153-159.
64. Witztum JL & Steinberg D (2001) The oxidative modification hypothesis of atherosclerosis: Does it hold for humans? Trends Cardiovasc Med 11, 93-102.
65. Wu D, Koga T, Martin KR & Meydani M (1999) Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes. Atherosclerosis. 147, 297-307.